Skip to main content
Loading market data...
ETF NYSE Arca USD

Alger Russell Innovation ETF INVN

Issuer: not identified from the fund name SEC registrant: Alger ETF Trust Equity · US
Last price 27.18 USD Change: Up +0.64 Percent change: Up +2.42%

Source: Yahoo Finance (opens in a new tab) Observed · 1 day ago Quotes may be delayed

Net expense ratio
0.55%
Prospectus 30 Apr 2026
Net assets
$9.6M
As of 30 Jun 2026
Holdings
51
As of 30 Jun 2026
12-month distribution yield
0.23%
Irregular
Asset class
Equity
From holdings

Alger Russell Innovation ETF (INVN) is an exchange-traded fund listed on NYSE Arca in the United States. Its category is Equity · US (equity). Its last price was US$27.18 on 20 Oct 2026. Its net expense ratio is 0.55% a year, from its prospectus dated 30 Apr 2026. It reported net assets of US$9.64 million as of 30 Jun 2026. Its latest holdings report lists 51 holdings as of 30 Jun 2026. Over the last 12 months it paid distributions of US$0.0620 a unit, a 12-month distribution yield of 0.23%.

General information only: nothing on TakeProfits takes into account your objectives, financial situation or needs, and it isn't personal financial advice or a recommendation to buy or sell anything. Consider whether it suits you and get advice from a licensed adviser before acting. Market data may be delayed and comes from third-party sources.

Fees

Total annual operating expenses (gross)
1.34%
Net, after fee waivers or reimbursements
0.55%
Management fee
0.45%
Prospectus date
30 Apr 2026
Filed with the SEC
28 Apr 2026

Size and reporting

Net assets
$9,640,435
Total assets
$9,689,065
Holdings as of
30 Jun 2026
Report made public
27 Aug 2026 (58 days after the month end)

Net assets are for the whole fund series, which for some funds (Vanguard's, for example) also includes mutual fund share classes.

Top holdings

Largest 25 of 51 positions, as of 30 Jun 2026. Weight is the percent of net assets the fund reported.

INVN top holdings as of 30 Jun 2026
# Holding Identifier Weight Value (USD) Type Country Currency
1 ROBLOX CORP ROBLOX CORP CL A US7710491033 2.57% $248K Equity (common) United States USD
2 ZEBRA TECHNOLOGIES CORP ZEBRA TECHNOLOGIES CORP CL A US9892071054 2.38% $230K Equity (common) United States USD
3 EXPEDIA GROUP INC EXPEDIA GROUP INC COM NEW US30212P3038 2.29% $221K Equity (common) United States USD
4 MAPLEBEAR INC MAPLEBEAR INC COM US5653941030 2.25% $217K Equity (common) United States USD
5 BLOCK INC BLOCK INC CL A US8522341036 2.24% $216K Equity (common) United States USD
6 ZSCALER INC ZSCALER INC COM US98980G1022 2.22% $214K Equity (common) United States USD
7 BILL HOLDINGS INC BILL HOLDINGS INC COM US0900431000 2.19% $211K Equity (common) United States USD
8 BIOGEN INC BIOGEN INC COM US09062X1037 2.18% $210K Equity (common) United States USD
9 CCC INTELLIGENT SOLUTIONS HOLDINGS INC CCC INTELLIGENT SOLUTIONS HOLDINGS INC COM US12510Q1004 2.15% $208K Equity (common) United States USD
10 ETSY INC ETSY INC COM US29786A1060 2.15% $207K Equity (common) United States USD
11 LYFT INC LYFT INC CL A COM US55087P1049 2.14% $206K Equity (common) United States USD
12 DYNATRACE INC DYNATRACE INC COM NEW US2681501092 2.12% $205K Equity (common) United States USD
13 MERCK & COMPANY INC MERCK & COMPANY INC COM US58933Y1055 2.12% $204K Equity (common) United States USD
14 INCYTE CORP INCYTE CORP COM US45337C1027 2.11% $203K Equity (common) United States USD
15 UNITY SOFTWARE INC UNITY SOFTWARE INC COM US91332U1016 2.10% $203K Equity (common) United States USD
16 GITLAB INC GITLAB INC CLASS A COM US37637K1088 2.10% $203K Equity (common) United States USD
17 PAYPAL HOLDINGS INC PAYPAL HOLDINGS INC COM US70450Y1038 2.08% $201K Equity (common) United States USD
18 GODADDY INC GODADDY INC CL A US3802371076 2.07% $200K Equity (common) United States USD
19 JAZZ PHARMACEUTICALS PLC JAZZ PHARMACEUTICALS PLC SHS USD IE00B4Q5ZN47 2.06% $199K Equity (common) Ireland USD
20 NEUROCRINE BIOSCIENCES INC NEUROCRINE BIOSCIENCES INC COM US64125C1099 2.06% $198K Equity (common) United States USD
21 KLAVIYO INC KLAVIYO INC COM SER A US49845K1016 2.04% $197K Equity (common) United States USD
22 BRISTOL-MYERS SQUIBB COMPANY BRISTOL-MYERS SQUIBB COMPANY COM US1101221083 2.03% $196K Equity (common) United States USD
23 REGENERON PHARMACEUTICALS INC REGENERON PHARMACEUTICALS INC COM US75886F1075 2.03% $196K Equity (common) United States USD
24 EXELIXIS INC EXELIXIS INC COM US30161Q1040 2.03% $196K Equity (common) United States USD
25 NUTANIX INC NUTANIX INC CL A US67059N1081 2.01% $194K Equity (common) United States USD

Breakdowns

Sums of reported weights over every position in the report. Totals can differ from 100% because of derivatives, borrowing and cash.

Asset type

Asset type by weight
TypeWeightBar
Equity (common) 100.33%
Short-term investment vehicles (cash funds) 0.15%

Country

Country by weight
CountryWeightBar
United States 94.84%
Ireland 2.06%
Netherlands 1.84%
Guernsey 1.74%

Currency exposure

Currency exposure by weight
CurrencyWeightBar
US dollar (USD) 100.48%

Sector

Sector weights for holdings matched to listed stocks
SectorWeightBar
Technology 55.21%
Health Care 18.41%
Consumer Discretionary 10.85%
Industrials 6.45%
Miscellaneous 1.95%

Source: SEC Form N-PORT (opens in a new tab) Holdings as of

Distributions

Paid in the last 12 months
$0.0620
1 payment per unit
12-month yield
0.23%
Distributions only, not total return
Frequency
Irregular
From the gaps between ex-dates
Latest ex-date
18 Dec 2025

12-month yield = distributions per unit with an ex-date in the last 12 months ($0.0620) ÷ latest price ($27.18) × 100 = 0.23%. It looks back, so it is not a forecast; special distributions in the window are included.

Why a distribution yield is not the fund's return: yield vs total return

Distribution history table (1 payments)
INVN distributions per unit by ex-date
Ex-dateAmount per unit
18 Dec 2025$0.0620

Filings and sources

Compare with

Largest funds in the same category:

Up to four symbols separated by commas. ASX funds end in .AX, for example IVV.AX.

How ETF overlap is measured, with a worked example

IMPORTANT FINANCIAL DISCLAIMER: The information provided on this platform is for educational and informational purposes only and should not be construed as investment advice. All investments involve risk, including potential loss of principal. Past performance does not guarantee future results. Take Profits is not a registered investment advisor and does not provide personalized investment advice. Users should conduct their own research and consult with qualified financial professionals before making investment decisions. Market data may be delayed and is provided by third-party sources.

Catalyst evidence

Loading…

Loading evidence…

Supporting sources

    Skip to main content

    All resources and tools

    Market ticker

    Markets

    Research

    Tools

    My investments

    Account

    Region and currency

    Colour theme